Dáil Éireann Debate, Tuesday - 21 April 2026
799. Deputy Ken O'Flynn asked the Minister for Health whether any formal expenditure ceiling, cap, or upper limit applies to funding approvals under the treatment abroad scheme; if so, the value of such limits; and if no such ceiling exists, the rationale for the absence of expenditure controls in a publicly funded scheme. [28118/26]
Amharc ar fhreagra800. Deputy Ken O'Flynn asked the Minister for Health whether there is a maximum cost threshold per patient under the treatment abroad scheme; if so, the level at which additional approvals are required; and the approval process triggered when such thresholds are exceeded. [28119/26]
Amharc ar fhreagra801. Deputy Ken O'Flynn asked the Minister for Health the approval hierarchy in place for treatment abroad scheme funding decisions, including the grade or role of officials authorised to approve standard applications and high-cost or complex cases; and whether Ministerial or Departmental sanction is required above specified thresholds. [28120/26]
Amharc ar fhreagra805. Deputy Ken O'Flynn asked the Minister for Health the specific oversight mechanisms exercised by her Department in relation to the treatment abroad scheme, including whether regular reporting, budget monitoring, or performance review processes are in place; and the frequency of such oversight. [28124/26]
Amharc ar fhreagra809. Deputy Ken O'Flynn asked the Minister for Health to identify the specific division within her Department responsible for oversight of treatment abroad scheme expenditure; the grade and title of the official designated as budget holder for the Scheme; and whether that individual has formal responsibility for approving or rejecting expenditure variances. [28128/26]
Amharc ar fhreagra810. Deputy Ken O'Flynn asked the Minister for Health whether a defined annual budget ceiling is set for the treatment abroad scheme; if so, the ceiling in each year from 2020 to 2026; and the process by which expenditure exceeding projections is approved or sanctioned. [28129/26]
Amharc ar fhreagraI propose to take Questions Nos. 799, 800, 801, 805, 809 and 810 together.
The Treatment Abroad Scheme operates within the overall health expenditure framework approved by the Oireachtas through the Estimates process and reflected in the HSE National Service Plan. The HSE is required, under the Performance and Accountability Framework agreed with my Department, to deliver all services, including the Treatment Abroad Scheme, within its overall annual budget allocation and to put in place appropriate governance, monitoring and financial controls.
While access to the Treatment Abroad Scheme is determined by individual clinical eligibility rather than fixed activity quotas, it is not exempt from budgetary oversight. Expenditure on the scheme is monitored as part of the HSE’s monthly financial reporting, and pressures arising within the scheme must be managed by the HSE within its overall annual budget allocation.
There are no financial caps applied to referrals under the Treatment Abroad Scheme. Notwithstanding that treatment costs are set by external health systems, the HSE applies statutory eligibility, prior approval, verification and audit controls, with my Department assuring value for money at system level through the budgetary and performance framework within which the HSE operates.
As the detailed operation of the Treatment Abroad Scheme, including the specific control measures in place, is an operational matter for the HSE, I have referred the Deputy’s question to the HSE for direct response.
